We are live on ! Find out more
PC

Pavadi Capital Portfolio holdings

AUM $81.2M
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
+7.2%
1 Year Est. Return
+5.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$85.7M
AUM Growth
-$5.89M
Cap. Flow
-$9.53M
Cap. Flow %
-11.11%
Top 10 Hldgs %
73.67%
Holding
18
New
2
Increased
1
Reduced
12
Closed
3

Top Buys

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$6.03M
2
PDCO
Patterson Companies, Inc.
PDCO
+$5.36M
3
HUM icon
Humana
HUM
+$2.01M

Top Sells

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$6.02M
2
MDT icon
Medtronic
MDT
+$5.91M
3
LNTH icon
Lantheus
LNTH
+$1.84M
4
MCK icon
McKesson
MCK
+$1.35M
5
THC icon
Tenet Healthcare
THC
+$1.22M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
1
Tenet Healthcare
THC
$20.5B
$8.4M 9.81%
103,280
-17,152
-14% -$1.22M
AMN icon
2
AMN Healthcare
AMN
$1.3B
$7.03M 8.2%
64,395
-11,612
-15% -$1.1M
MOH icon
3
Molina Healthcare
MOH
$10.2B
$6.54M 7.63%
21,723
-3,697
-15% -$1.06M
PDCO
4
DELISTED
Patterson Companies, Inc.
PDCO
$6.47M 7.54%
+194,384
New +$5.36M
BAX icon
5
Baxter International
BAX
$13.5B
$6.41M 7.47%
140,613
-17,114
-11% -$745K
HUM icon
6
Humana
HUM
$43.7B
$5.96M 6.95%
13,330
+3,987
+43% +$2.01M
AVTR icon
7
Avantor
AVTR
$9.32B
$5.87M 6.84%
285,624
-12,159
-4% -$246K
QDEL icon
8
QuidelOrtho
QDEL
$1.14B
$5.71M 6.66%
+68,864
New +$6.03M
LNTH icon
9
Lantheus
LNTH
$6.49B
$5.65M 6.6%
67,384
-20,495
-23% -$1.84M
NVST icon
10
Envista
NVST
$4.44B
$5.12M 5.97%
151,245
-27,443
-15% -$968K
CNC icon
11
Centene
CNC
$30.7B
$4.84M 5.65%
71,801
-2,138
-3% -$143K
HCA icon
12
HCA Healthcare
HCA
$87.2B
$4.67M 5.44%
15,378
-2,646
-15% -$736K
IART icon
13
Integra LifeSciences
IART
$1.29B
$4.6M 5.37%
111,955
-16,803
-13% -$809K
CVS icon
14
CVS Health
CVS
$133B
$4.35M 5.07%
62,918
-2,250
-3% -$160K
UNH icon
15
UnitedHealth
UNH
$376B
$4.1M 4.79%
8,535
-1,240
-13% -$606K
CAH icon
16
Cardinal Health
CAH
$53.9B
– –
-79,800
Closed -$6.02M
MCK icon
17
McKesson
MCK
$100B
– –
-3,791
Closed -$1.35M
MDT icon
18
Medtronic
MDT
$109B
– –
-73,295
Closed -$5.91M

Similar funds

BAM
Broadmark Asset Management San Francisco, California $80.4M AUM 29.98% 1-Year Est. Return
TCM
Tegean Capital Management New York $82.1M AUM 12.91% 1-Year Est. Return
JAM
JLP Asset Management New York $84.2M AUM 10.86% 1-Year Est. Return
HH
HP Holding New York $84.5M AUM 4.73% 1-Year Est. Return
CPI
Canaan Partners IX Menlo Park, California $87.5M AUM
SLM
Snow Lake Management Menlo Park, California $90.7M AUM 72.65% 1-Year Est. Return
AFG
Alterity Financial Group Bangor, Maine $69.9M AUM 40.65% 1-Year Est. Return
TIMH
Tilt Investment Management Holdings New York $92.6M AUM 28.92% 1-Year Est. Return

Pavadi Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Pavadi Capital held 18 positions worth $85.7M, down 6.4% from $91.6M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Pavadi Capital withdrew a net $9.53M in Q2 2023, closing 3 positions and reducing 12 holdings. Its most notable exit was Cardinal Health, an estimated $6.02M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Pavadi Capital opened a new position in QuidelOrtho worth $5.71M.

  • Pavadi Capital's largest Q2 2023 buy was QuidelOrtho: 68,864 shares worth $5.71M.
  • Pavadi Capital added most to Humana in Q2 2023, an estimated $2.01M increase.
  • Pavadi Capital's biggest Q2 2023 reduction was Lantheus, cutting an estimated $1.84M.
  • Pavadi Capital fully exited Cardinal Health in Q2 2023, selling an estimated $6.02M.
  • Pavadi Capital's ten largest holdings make up 74% of its $85.7M portfolio in Q2 2023.
  • Pavadi Capital opened 2 new positions and closed 3 in Q2 2023.
  • Pavadi Capital's portfolio value fell 6.4% quarter-over-quarter to $85.7M.

Based on Pavadi Capital's 13F filing for Q2 2023, filed 14 Aug 2023.